Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-02-22 Purchase | 2019-02-26 9:08 pm | Sienna Biopharmaceuticals Inc. | SNNA | ARCH Venture Partners X LLC ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT GILLIS STEVEN 10% Owner | 2,165,800 | $2.5 | $5,414,500 | 1,865,800 (Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 9:06 pm | Sienna Biopharmaceuticals Inc. | SNNA | ARCH Venture Partners VIII LLC ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. ARCH Venture Partners VIII L.P. BYBEE CLINTON CRANDELL KEITH NELSEN ROBERT 10% Owner | 2,165,800 | $2.5 | $5,414,500 | 1,865,800 (Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 9:03 pm | Sienna Biopharmaceuticals Inc. | SNNA | Burow Kristina Director | 2,165,800 | $2.5 | $5,414,500 | 1,865,800 (Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 5:16 pm | Sienna Biopharmaceuticals Inc. | SNNA | MORE ROBERT J Director | 100,000 | $2.5 | $250,000 | 255,942 (Direct) | View |
| 2019-02-22 Purchase | 2019-02-26 5:14 pm | Sienna Biopharmaceuticals Inc. | SNNA | Leonard Keith R Director | 100,000 | $2.5 | $250,000 | 148,484 (Indirect Direct) | View |
| 2019-02-22 Purchase | 2019-02-26 5:12 pm | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 40,000 | $2.5 | $100,000 | 944,276 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-10-02 Tax Withholding | 2019-10-04 2:10 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 2,396 | $0.23 | 103,552 (Direct) | View |
| 2019-08-06 Disposition | 2019-08-08 4:44 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 131,808 | $0 | 302,366 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 4:44 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 181,808 | $0 | 302,366 (Direct) | View |
| 2019-08-06 Disposition | 2019-08-08 4:42 pm | N/A 2027-12-01 | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 68,100 | $0 | 174,048 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 4:42 pm | N/A 2027-12-01 | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 138,100 | $0 | 174,048 (Direct) | View |
| 2019-08-06 Disposition | 2019-08-08 4:40 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 120,550 | $0 | 327,595 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 4:40 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 175,550 | $0 | 327,595 (Direct) | View |
| 2019-08-06 Disposition | 2019-08-08 4:38 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 461,968 | $0 | 1,542,181 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 4:38 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 611,968 | $0 | 1,542,181 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:47 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Stroehmann Diane See Remarks | 4,095 | $0.76 | 168,545 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:42 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 4,095 | $0.76 | 120,558 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:39 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 4,095 | $0.76 | 152,045 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:36 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 1,552 | $0.76 | 35,948 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:35 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 17,063 | $0.76 | 930,213 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:41 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Burow Kristina Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:38 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | MORE ROBERT J Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:35 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Leonard Keith R Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:32 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Hindman James M. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:29 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Harris Todd Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:24 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | FENTON DENNIS M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-04-01 Option Award | 2019-04-03 5:44 pm | N/A 2029-04-01 | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 20,000 | $0 | 57,500 (Direct) | View |
Ownership | 2019-04-03 5:23 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Azoy Alexander Chief Financial Officer | 0 | $0 | 65,600 (Direct) | View |
Ownership | 2019-02-14 6:15 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | MORE ROBERT J Director | 0 | $0 | 155,942 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:21 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Stroehmann Diane See Remarks | 104,632 | $0 | 254,772 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:19 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Smither John W Chief Financial Officer | 104,422 | $0 | 163,540 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:16 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Lizzul Paul F. Chief Medical Officer | 104,904 | $0 | 235,544 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:13 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 108,290 | $0 | 210,443 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:11 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Beddingfield III Frederick President & CEO | 415,968 | $0 | 1,226,494 (Direct) | View |